Illumina, General Atlantic and Viking Global have supplied $70m for Ginkgo Bioworks, an MIT spinout that has now raised more than $789m altogether.
Ginkgo Bioworks, a US-based microbe engineering services spinout of Massachusetts Institute of Technology, has received $70m in funding from genomics technology producer Illumina, growth equity firm General Atlantic and hedge fund manager Viking Global Investors.
Founded in 2009, Ginkgo has developed cell programming technology that is capable of growing organisms for industrial applications such as nutritional products, consumer goods and fragrances.
Gingko has itself established a series of spinoffs including microbiome technology producer Joyn Bio and alternative…
